(Q54589176)

1 June 2018

title

Magnesium-induced reversal of vitamin-D resistance in hypoparathyroidism. (English)

1 reference

1 June 2018

0 references

0 references

1 reference

A Rösler

1

1 reference

1 June 2018

D Rabinowitz

series ordinal

2

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 April 1973

1 reference

1 June 2018

published in

The Lancet

1 reference

1 June 2018

volume

1

1 reference

1 June 2018

issue

7807

1 reference

1 June 2018

page(s)

803-804

1 reference

1 June 2018

Refractoriness to antitetanic therapy in a case of surgical hypoparathyroidism

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

Insensitivity of vitamin D developing during the treatment of postoperative tetany; its specificity as regards the form of vitamin D taken

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

Hypoparathyroidism requiring massive amounts of medication, with apparent response to magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

Hypocalcemia Due to Hypomagnesemia and Reversible Parathyroid Hormone Unresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

In vitro production of 25-hydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2990602-8

7 January 2021

10.1016/S0140-6736(73)90602-8

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018